National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial is a research paper published in Breast Cancer Research and Treatment (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: 1K08CA276706
NCI NIH HHS
Grant: K08 CA276706
National Institutes of Health
Grant: 5K08CA276706-02
Understanding Breast Cancer Risk and Screening in Transgender Persons through a Pilot Breast Cancer Screening Program
Fields of Study
MeSH Terms
Keywords